Press Releases - Helio Genomics
See what we're up to
in the news.

Stay up to date with how Helio is transforming the paradigm of early cancer detection.

Be in the loop

Stay on top of the latest Helio happenings and see our latest press releases

The American Medical Association Approves a New Category I CPT® Code for the HelioLiver™ Test

/PRNewswire/ -- Helio Genomics ("Helio"), and its commercial partner, Fulgent Genetics (NASDAQ: FLGT) ("Fulgent") announced that the American Medical...

July 05, 2022

HelioLiver™, an Innovative Liquid Biopsy Test for the Early Detection of Liver Cancer, is Now Commercially Available

Helio Genomics and its commercial partner, Fulgent Genetics, Inc. (NASDAQ: FLGT), today announced the commercial launch of HelioLiver™, a multi-analyte blood test that incorporates...

December 06, 2021

Helio Genomics and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiver™ for Early Liver Cancer Detection

IRVINE, Calif. and TEMPLE CITY, Calif., Nov. 8, 2021 /PRNewswire/ -- Helio Genomics and its commercial partner, Fulgent Genetics, Inc...

November 08, 2021

Helio Genomics and Fulgent Genetics to Present New Data on HelioLiver in Late-Breaking Presentation at The Liver Meeting® 2021c

IRVINE, Calif. and TEMPLE CITY, Calif., Nov. 1, 2021 /PRNewswire/ -- Helio Genomics, an AI-driven healthcare company developing blood-based early cancer detection tests, and Fulgent Genetics, Inc. (NASDAQ: FLGT)...

November 01, 2021

FUJIFILM Medical Systems U.S.A., Inc. and Helio Genomics Collaborate to Advance Blood-based Screening Methods for Early-Stage Liver Cancer

Collaboration enables acceleration of early cancer detection and surveillance Lexington, Mass. and Irvine, CA

May 12, 2021

Helio Genomics Recognized for Diagnostics Technology Innovation in 2021 MedTech Breakthrough Awards Program

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies

May 06, 2021

Helio Genomics and National Cancer Center Awarded Grant from Ministry of Science and Technology to Evaluate HelioLiver Test in Real-World Screening Scenario in China

Strategic partnership with NCC enables accelerated development of its HelioLiver Test for early liver cancer detection and screening

April 28, 2021

Helio Genomics Announces China NMPA Acceptance of Registration Application for HelioLiver Test

Liver cancer is the fastest growing and second deadliest cancer worldwide In China alone, more than 400,000 liver cancer diagnoses per year and nearly 100 million people living with hepatitis B virus.

March 24, 2021

Helio Genomics to Participate in the 41st Annual Cowen Healthcare Conference

Helio Genomics, an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced its participation in the 41st Annual Cowen Healthcare Conference.

February 25, 2021

Webcast of Helio Genomics Fireside Chat at the 2021 BTIG Virtual MedTech, Digital health, Life Science & Diagnostic Tools Conference

Webcast of Helio Genomics Fireside Chat at the 2021 BTIG Virtual MedTech, Digital health, Life Science & Diagnostic Tools Conference

February 17, 2021

Helio Genomics to Participate in 10th Annual SVB Leerink Global Healthcare Conference

Helio Genomics, announced its participation in the 10th Annual SVB Leerink Global Healthcare Conference, which takes place February 22-26, 2021.

February 11, 2021

Helio Genomics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Helio Genomics announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 17-19, 2021.

February 03, 2021

Positive Data Presented on Helio Genomics Liver Test for the Detection of Hepatocellular Carcinoma (HCC) Advances Product Development

New data demonstrate high accuracy of blood-based cfDNA methylation test for the detection of HCC. Test has potential to outperform current screening modalities for early stage HCC within high risk populations.

November 13, 2020

Helio Genomics Appoints Wei Li, Ph.D., Leading Expert in Large-Scale Genomics and Bioinformatics, as Key Scientific Advisor

Endowed Chair and Professor of Bioinformatics for the Department of Biological Chemistry at the University of California, Irvine's School of Medicine to Expand AI Expertise.

October 06, 2020

Helio Genomics Announces Collaboration with Top National Cancer Centers

Researchers to Study the Helio Genomics Liquid Biopsy Cancer Test's Efficacy in Detecting Liver Cancer.

September 10, 2020

Laboratory for Advanced Medicine Announces New China CEO Position to Commercialize its Early Cancer Diagnostic for Liver and Colon Cancer Detection in Asia

Laboratory for Advanced Medicine, an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced the appointment of prominent business leader and...

June 15, 2020

Laboratory for Advanced Medicine Appoints Former Ancestry Executive as Chief Operations Officer

Laboratory for Advanced Medicine, an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced the appointment of Benjamin Oyler as Chief Operating Officer.

February 18, 2020

Laboratory For Advanced Medicine Appoints Aarif Nakhooda as Chief Financial Officer

Laboratory for Advanced Medicine, an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced the appointment of Aarif Nakhooda as Chief Financial Officer. Mr. Nakhooda has more than 25 years...

December 19, 2019

Laboratory For Advanced Medicine Adds High-Profile Cigna Health Senior Executive To Its Board of Directors

IRVINE, Calif., Dec. 3, 2019 /PRNewswire/ -- Laboratory for Advanced Medicine, an AI-driven healthcare company focused on commercializing early cancer detection test from a simple blood draw, today announced the appointment of Christopher DeRosa, MBA...

December 03, 2019

Laboratory for Advanced Medicine Presents New Liver Cancer Test Data at The Liver Meeting 2019

IRVINE, Calif., Nov. 12, 2019 /PRNewswire/ -- Laboratory for Advanced Medicine, an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced that it will be presenting new data supporting its methylation-based...

November 12, 2019

Laboratory for Advanced Medicine Appoints Kenneth Chahine, Ph.D., J.D., as Chief Executive Officer

Laboratory for Advanced Medicine, an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced the appointment of Kenneth Chahine, Ph.D., J.D., as Chief Executive Officer and board member...

November 07, 2019

Laboratory for Advanced Medicine Appoints to its Board of Directors Dr. Alan List, President and CEO, Moffitt Cancer Centerc

IRVINE, Calif., Oct. 23, 2019 /PRNewswire/ -- Laboratory for Advanced Medicine, an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced the appointment of Alan List, M.D...

October 23, 2019

Laboratory for Advanced Medicine Receives FDA Breakthrough Device Designation for Liquid Biopsy Liver Cancer Detection Test

Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company with innovative technologies for the early diagnosis of cancer, today announced that its Liver Cancer detection test has been granted Breakthrough Device...

September 03, 2019

Laboratory for Advanced Medicine Strengthens Hepatology Board with Addition of Three Distinguished Medical Doctors

Dr. Abou-Alfa, oncologist at Memorial Sloan Kettering; Dr. Gish, Medical Director of Hepatitis B Foundation; and Dr. Hoshida, Director of Translational Research in Liver Cancer at the University of Texas Southwestern Medical Center...

August 08, 2019

LAM's IvyGene Liquid Biopsy Platform Demonstrates High Diagnostic Capabilities In New Cancer Indication

Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company focused on developing innovative technologies for the early diagnosis of cancers, today announced positive results from a new study that evaluated DNA...

May 15, 2019

LAM Announces New Data Demonstrating High Diagnostic Potential Of Cell-Free DNA Methylation Assay For Early, Non-Invasive Detection Of Liver, Breast And Colorectal Cancers At AACR 2019

IRVINE, Calif., March 31, 2019 -- Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company focused on developing innovative technologies for the early diagnosis of cancers, today announced new data...

March 31, 2019

LAM to Present Data for Cell-Free DNA Methylation Assay for Non-Invasive Diagnosis of Liver, Breast and Colorectal Cancers at AACR Annual Meeting 2019

IRVINE, Calif., Mar. 20, 2019 — Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company focused on developing innovative technologies for the early diagnosis of cancers...

March 20, 2019

Laboratory for Advanced Medicine Announces New Data Demonstrating High Diagnostic Potential of DNA Methylation-Based Biomarkers for Early and Noninvasive Diagnosis of Breast Cancer at San Antonio Breast Cancer Symposium

IRVINE, Calif., Dec. 7, 2018 — Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company focused on developing innovative technologies for the early diagnosis...

December 07, 2018

LAM to Present Data Demonstrating Efficacy of DNA Methylation as Epigenetic Biomarkers for Non-Invasive Breast Cancer Detection at Upcoming San Antonio Breast Cancer Symposium

IRVINE, Calif., Nov. 20, 2018 — Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company focused on developing innovative technologies for the early diagnosis of cancers...

November 20, 2018

LAM Announces New Data Validating High Sensitivity and Specificity of DNA Methylation-Based Biomarkers for Noninvasive Diagnosis of Liver Cancer at SITC Meeting

IRVINE, Calif., Nov. 6, 2018 — Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company focused on developing innovative technologies for the early diagnosis of cancers...

November 06, 2018

LAM Announces Presentation of DNA Methylation-Based Biomarker Data for Noninvasive Diagnosis of Hepatocellular Carcinoma at SITC 2018

IRVINE, Calif., Oct. 23, 2018 — Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company focused on developing innovative technologies for the early diagnosis of cancers...c

October 23, 2018

Laboratory for Advanced Medicine Appoints Jinjie Hu as Chief Regulatory Officer

IRVINE, Calif., July 12, 2018 /PRNewswire/ -- Laboratory for Advanced Medicine (LAM), a clinical-stage medical technology company focused on developing innovative technologies for the early diagnosis and intervention of cancers...

July 12, 2018

Laboratory for Advanced Medicine to Present at 2018 BIO International Convention

IRVINE, Calif., June 4, 2018 — Laboratory for Advanced Medicine (LAM), a clinical-stage medical technology company developing innovative technologies for the early diagnosis and intervention of cancers, today announced that Justin Li...

June 04, 2018

Laboratory for Advanced Medicine Commercializes Non-Invasive, Artificial Intelligence-Based IvyGene Blood Test for Cancer Detection

IRVINE, Calif., May 30, 2018 — Laboratory for Advanced Medicine (LAM), a clinical-stage medical technology company developing innovative technologies for the early diagnosis...

May 30, 2018

Laboratory for Advanced Medicine Appoints Richard Brand as Chief Financial Officer

IRVINE, Calif., May 17, 2018 — Laboratory for Advanced Medicine (LAM), a clinical-stage medical technology company focused on developing innovative technologies for the early diagnosis...

May 17, 2018

Firefighters Against Cancer and Exposures (FACES) Non-Profit Launches in Texas

IRVINE, Calif., March 14, 2018 — In an effort to help firefighters cover the high cost of cancer treatment as a result of the occupational risk of experiencing higher rates of certain types of cancer than the general U.S. population, Laboratory for Advanced Medicine (LAM) today announced the launch of…

May 14, 2018
Helio Genomics ribbon
Need More Info?
We’re happy to hear from you and answer any questions you have about Helio.